MSPT (Master of Physical Therapy), MD - Medicine and Surgery, Master of Science in Preventive, Anti-Aging and Regenerative Medicine
20 Years Experience Overall
Dr. Puyat is the founder and medical director of ASCI. She received her medical degree from the University of Santo Tomas, and completed her residency in dermatology at the Jose R. Reyes Memorial Medical Center, Manila, Philippines. She has a fellowship in dermatology and dermatological surgery from the Baylor College of Medicine in Texas (USA). She has a Master’s degree in Preventive and Regenerative Medicine from the Dresden International University (Germany), a Masters in biotechnology from American University, and a Stem Cell fellowship from the American Academy of Anti-Aging Medicine.Dr. Puyat is a Member and a Board of Director of the Philippine Academy of Dermatologic Surgery Foundation Inc. (PADSFI), a member of the Asia-Pacific Restylane Fillers Advisory Committee (APAC/TAC), part of the Menarini Asia-Pacific Consensus, a Fellow of the American Academy of Dermatology (AAD), a member of International Society of Dermatologic Surgery (ISDS), a Charter Member of Philippine Society of Liposuction Surgery, a Fellow of Philippine Dermatologic Society (PDS), and a member of the American Academy of Anti-Aging Medicine (A4M). Dr. Puyat is an invited faculty and panel expert in topics ranging from dermatology to regenerative cellular therapies. She has been an invited faculty at the International Darmstadt Live Symposium in Germany numerous times, and has served in the capacity as a facilitator, faculty, chair and co-chair for the ISDS in Istanbul, Las Vegas, Philippines, Vienna, Thailand, Bucharest, Luzern, and New Delhi; DASIL, APACS, A4M, WOSIAM, Euromedicom Aesthetic Asia, IMCAS, and World Consensus for WOCPM, and ITCAM Anatomy Master Courses. Dr. Puyat’s most recent peer review study “Volumetric Changes After a Stem Cell Facelift: A Multiple Case Study” is published in the April 2014 issue of Prime International Journal of Aesthetic and Anti-Aging Medicine.